Cell-type-specific NRXN1alpha alternative splicing changes in psychiatric disease
Cell-type-specific NRXN1alpha alternative splicing changes in psychiatric disease
批准号:
9980504
负责人:
Kristen Jennifer Brennand
金额:
$80.94万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-18 至 2024-04-30
关键词:
3-DimensionalAdultAffectAffinityAge of OnsetAllelesAlternative SplicingAmericanAutopsyBehavioralBindingBipolar DisorderBrainCatalogsCell CommunicationCell modelClinicalComplexDataDevelopmentDiagnosisDiagnosticDominant-Negative MutationElectrophysiology (science)EquilibriumExhibitsFailureGenesGeneticGenomicsGenotypeGlutamatesGoalsHumanImpairmentLengthLigandsLinkMental disordersModelingMusMutationNeurodevelopmental DisorderNeuronsOrganoidsPatientsPenetrancePhysiologicalPopulationProsencephalonProtein IsoformsPsychotic DisordersRNA SplicingResearchResearch PersonnelSchizophreniaSeveritiesSiteSynapsesTestingTissuesWorkautism spectrum disorderbasecase controlcell typeclinical predictorsexcitatory neuronfetalimprovedin vivoinduced pluripotent stem cellinhibitory neuronmouse modelmulti-electrode arraysmutantneural circuitneuropsychiatric disorderneurotransmitter releasenovelnovel therapeutic interventionoutcome forecastoverexpressionpostsynapticpostsynaptic neuronspredict clinical outcomepresynapticpresynaptic neuronsrecruitsingle cell analysissingle-cell RNA sequencingstandard caresynaptic functionsynaptogenesis
中文摘要
项目总结
精神分裂症、双相情感障碍和自闭症是常见的、使人衰弱的神经发育障碍
加在一起,影响了500多万美国人。尽管进行了50多年的研究,但目前还没有治愈方法,而且
治疗标准仍然不能令人满意。Neuresin-1(NRXN1)的杂合突变已被
反复与精神分裂症(SZ)和自闭症谱系障碍(ASD)有关。临床表现
受影响患者的NRXN1+/-突变(包括诊断、严重程度、预后和发病年龄)为
这些突变是多种多样的,影响这些突变外显的遗传机制尚不清楚。此外,
小鼠模型不允许研究人员研究一些NRXN1+/-缺失如何以及为什么会有更多
对病人的有害影响。我们的目标是解决NRXN1+/-缺失如何干扰NRXN1亚型
曲目和影响神经元成熟和突触功能。我们的初步数据定义了NRXN1
控制胎儿和成人皮质组织的选择性剪接谱系,并与人类诱导的
来自NRXN1+/-病例和对照的多能干细胞(HiPSC)来源的神经元。在此,我们建议
评估对照和NRXN1+/-中NRXN1亚型谱系的实验操作效果
病人来源的兴奋性和抑制性神经元。最终,我们希望将基因组和
日益精炼的NRXN1+/-患者来源神经元群体的功能缺陷。
英文摘要
PROJECT SUMMARY
Schizophrenia, bipolar disorder and autism are common and debilitating neurodevelopmental disorders that
together affect more than 5 million Americans. Despite more than fifty years of research, no cures exist and the
standard of treatment remains unsatisfactory. Heterozygous mutations of neurexin-1 (NRXN1) have been
repeatedly associated with schizophrenia (SZ) and autism spectrum disorder (ASD). The clinical presentations
of NRXN1+/- mutations (including diagnosis, severity, prognosis and age-of-onset) in affected patients are
diverse and the genetic mechanism affecting the penetrance of these mutations remains unknown. Moreover,
mouse models do not permit researchers to study how and why some NRXN1+/- deletions have more
deleterious effects in patients. Our objective is to resolve how NRXN1+/- deletions perturb the NRXN1 isoform
repertoire and impact neuronal maturation and synaptic function. Our preliminary data defined the NRXN1
alternative splice repertoire in control fetal and adult cortical tissue, and compared this to human induced
pluripotent stem cell (hiPSC)-derived neurons from NRXN1+/- cases and controls. Here, we propose to
evaluate the effect of experimental manipulation of the NRXN1 isoform repertoire in both control and NRXN1+/-
patient-derived excitatory and inhibitory neurons. Ultimately, we hope to directly correlate genomic and
functional deficits across increasingly refined populations of NRXN1+/- patient-derived neurons.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
High-throughput in vivo and in vitro functional and multi-omics screens of neuropsychiatric and neurodevelopmental disorder risk genes
-
批准号:10643398
-
项目类别:
-
资助金额:$112.66万
-
财政年份:2023
-
负责人:Kristen Jennifer Brennand
-
依托单位:
Modeling the interaction of physiological and environmental stressors on common variants to psychiatric traits
-
批准号:10706811
-
项目类别:
-
资助金额:$93.11万
-
财政年份:2022
-
负责人:Kristen Jennifer Brennand
-
依托单位:
Resolving complex alternative splicing of psychiatric disease genes using single-cell approaches
-
批准号:10630216
-
项目类别:
-
资助金额:$75.69万
-
财政年份:2021
-
负责人:Kristen Jennifer Brennand
-
依托单位:
Modeling the interaction of physiological and environmental stressors on common variants to psychiatric traits
-
批准号:10337629
-
项目类别:
-
资助金额:$75.73万
-
财政年份:2021
-
负责人:Kristen Jennifer Brennand
-
依托单位:
Resolving complex alternative splicing of psychiatric disease genes using single-cell approaches
-
批准号:10462568
-
项目类别:
-
资助金额:$80.97万
-
财政年份:2021
-
负责人:Kristen Jennifer Brennand
-
依托单位:
Critical assessment of DNA adenine methylation in brain cells from healthy aging and Alzheimer's disease
-
批准号:10365337
-
项目类别:
-
资助金额:$74.57万
-
财政年份:2021
-
负责人:Kristen Jennifer Brennand
-
依托单位:
Functional convergence following disruption of diverse genes associated with neurodevelopmental disorders
-
批准号:10626945
-
项目类别:
-
资助金额:$75.78万
-
财政年份:2021
-
负责人:Kristen Jennifer Brennand
-
依托单位:
Functional convergence following disruption of diverse genes associated with neurodevelopmental disorders
-
批准号:10407989
-
项目类别:
-
资助金额:$79.65万
-
财政年份:2021
-
负责人:Kristen Jennifer Brennand
-
依托单位:
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease
-
批准号:10653036
-
项目类别:
-
资助金额:$84.7万
-
财政年份:2020
-
负责人:Kristen Jennifer Brennand
-
依托单位:
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease
-
批准号:10260473
-
项目类别:
-
资助金额:$84.75万
-
财政年份:2020
-
负责人:Kristen Jennifer Brennand
-
依托单位:
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease
-
批准号:10451659
-
项目类别:
-
资助金额:$84.7万
-
财政年份:2020
-
负责人:Kristen Jennifer Brennand
-
依托单位:
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease
-
批准号:10032808
-
项目类别:
-
资助金额:$84.59万
-
财政年份:2020
-
负责人:Kristen Jennifer Brennand
-
依托单位:
Cell-type-specific NRXN1alpha alternative splicing changes in psychiatric disease
-
批准号:10407104
-
项目类别:
-
资助金额:$78.99万
-
财政年份:2019
-
负责人:Kristen Jennifer Brennand
-
依托单位:
Cell-type-specific NRXN1alpha alternative splicing changes in psychiatric disease
-
批准号:10619023
-
项目类别:
-
资助金额:$74.11万
-
财政年份:2019
-
负责人:Kristen Jennifer Brennand
-
依托单位:
Shared Genetics and Risk Factors Between Epilepsy and Psychiatric Disease
-
批准号:10533822
-
项目类别:
-
资助金额:$52.56万
-
财政年份:2019
-
负责人:Kristen Jennifer Brennand
-
依托单位:
Shared Genetics and Risk Factors Between Epilepsy and Psychiatric Disease
-
批准号:10324570
-
项目类别:
-
资助金额:$49.08万
-
财政年份:2019
-
负责人:Kristen Jennifer Brennand
-
依托单位:
Cell-type-specific NRXN1alpha alternative splicing changes in psychiatric disease
-
批准号:10418823
-
项目类别:
-
资助金额:$78.35万
-
财政年份:2019
-
负责人:Kristen Jennifer Brennand
-
依托单位:
Cell-type-specific NRXN1alpha alternative splicing changes in psychiatric disease
-
批准号:10116021
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2019
-
负责人:Kristen Jennifer Brennand
-
依托单位:
Large-scale reprogramming and expression analysis of patient-derived neural cells in schizophrenia
-
批准号:9926728
-
项目类别:
-
资助金额:$80.48万
-
财政年份:2017
-
负责人:Kristen Jennifer Brennand
-
依托单位:
Large-scale reprogramming and expression analysis of patient-derived neural cells in schizophrenia
-
批准号:10165823
-
项目类别:
-
资助金额:$49.82万
-
财政年份:2017
-
负责人:Kristen Jennifer Brennand
-
依托单位:
海外基金